P rior studies have established that patients with inflammatory bowel disease, especially those with extensive and long-standing ulcerative colitis, have an increased risk of subsequent colorectal cancer (1) (2) (3) (4) (5) . These studies of ulcerative colitis, however, have been based on data from tertiary care settings, primarily in the United States and the United Kingdom. Others practising in similar geographic areas, particularly in the United States, have shown that the magnitude of risk may not be significant (6, 7) , while some have argued that the risk of cancer is not increased in patients with colitis (8) . A number of studies have also suggested that patients with Crohn's disease have an increased risk of colorectal cancer (9) (10) (11) . In Canada, some have assumed that the risk of cancer in patients with ulcerative colitis or Crohn's disease is similar to that observed in American centres, but, to date, there have been no published studies from Canada.
The present report describes an experience with colorectal cancer using a single clinician database, developed during a 20-year period, in 877 patients with Crohn's disease in a tertiary care teaching hospital setting. The results of this study indicate that colorectal cancer may complicate the clinical course of Crohn's disease, particularly in younger men with long-standing disease, but part of this increased risk may be due to possible factors associated with the presence of a residual rectal stump rather than to Crohn's disease per se.
CASE PRESENTATIONS Case 1:
A 59-year-old man was diagnosed with rectal cancer in 1995. He was initially evaluated for bloody diarrhea in 1965. At that time, sigmoidoscopy, rectal biopsy and barium enema revealed Crohn's disease involving the sigmoid colon with a normal rectum, and he received sulphasalazine until 1985. He was first evaluated at the University of British Columbia, Vancouver, British Columbia, in April 1989 for recurrent diarrhea. Colonoscopy showed segmental inflammatory changes from 40 to 60 cm proximal to the anal verge. The distal colorectum was completely normal. Upper gastrointestinal endoscopy revealed focal inflammatory changes in the gastric antrum and duodenum without granulomas. Tests for Helicobacter pylori were negative. Treatment with 5-aminosalicylate (Asacol, Proctor & Gamble Pharmaceuticals, Canada) was associated with resolution of symptoms. In 1993, repeat endoscopic studies of his upper and lower gastrointestinal tracts were normal, but a rectal biopsy showed focal inflammatory change with no dysplasia. In 1995, recurrent rectal bleeding occurred. Rectal examination revealed a palpable nodule. Sigmoidoscopy and biopsy confirmed the presence of an adenocarcinoma. Abdominoperineal resection revealed metastatic adenocarcinoma in two of five lymph nodes. By October 1995, radiation therapy and adjuvant chemotherapy with 5-fluorouracil were completed. Since 1995, he has remained well on 5-aminosalicylate alone, with no evidence of recurrent neoplastic disease. Case 2: A 46-year-old man was diagnosed with rectal stump cancer in 1990. Crohn's disease was first diagnosed in 1968 in Montreal, Quebec during a laparotomy for clinically suspected appendicitis. An ileocecal resection was done. In 1980, recurrent ileal disease was defined, and an ileosigmoid fistula was present. An intra-abdominal abscess was surgically drained, and additional small bowel and colon were resected. A rectal stump was created. In 1986, an anal fistula was diagnosed, and azathioprine was administered for almost one year, with apparent resolution of the anal disease. In 1986, he moved to Vancouver and was initially seen in 1990. Physical examination revealed a focal indurated area at the anal verge suggestive of a small perianal abscess. Results of a flexible sigmoidoscopy and rectal biopsy were normal. Treatment with metronidazole 1000 mg daily was provided but, due to persistent perianal symptoms and development of fever, he was hospitalized. A horseshoe-shaped posterior perirectal abscess was drained, but biopsy showed a mucinous rectal adenocarcinoma. Abdominoperineal resection was done; an infiltrating adenocarcinoma was present with one of four lymph nodes positive for metastatic disease. He received radiation therapy, and results of a subsequent endoscopic evaluation through his colostomy, with biopsies, were normal. In 1992, pulmonary metastases were initially detected. Chemotherapy with 5-fluorouracil and leucovorin failed to prevent recurrent pelvic disease and enlarging pulmonary lesions, with subsequent death. Case 3: A 29-year-old man first developed diarrhea in 1983 and, after barium radiographs in Victoria, British Columbia, Crohn's disease of the colon was diagnosed. He was treated with sulphasalazine and corticosteroid enemas. Symptoms initially resolved but then promptly recurred with weight loss. Colonoscopy confirmed the presence of extensive and deep ulcerations with rectal and cecal sparing; colonic biopsies showed inflammatory changes but no granulomas or dysplasia. Results of ileal biopsies were normal. He was treated with parenteral nutrition and intravenous corticosteroids. In April 1987, he declined surgical treatment, and a course of prednisone was completed by June 1987. He was referred for a second opinion in 1987; surgical treatment was again declined. He was followed-up elsewhere, where he was administered repeated blood transfusions for anemia. In December 1990, he developed an acute abdomen while playing football. Laparotomy showed a perforated rectosigmoid carcinoma with generalized peritonitis; biopsies confirmed the presence of a poorly differentiated adenocarcinoma involving the liver, with multiple nodules. Extensive bilateral bronchopneumonia developed, followed by death, and an autopsy confirmed the presence of advanced colorectal cancer with extensive hepatic metastases. Case 4: A 48-year-old man was diagnosed with rectal stump cancer in 1985. He had a subtotal colectomy for presumed ulcerative colitis in 1967. Later in the same year, he developed a peristomal abscess with a fistula to the ileum requiring terminal ileum resection and repositioning of his ileostomy; the resected ileum showed granulomatous inflammation, consistent with Crohn's disease. In 1985, purulent rectal stump drainage was first observed, leading to rectal stump excision; a well differentiated rectal carcinoma was present. No lymph nodes were involved, but local involvement of the proximal muscle margin was detected. Following the rectal stump excision, he had pelvic radiation. His perineal wound healed poorly with persistent drainage. Treatment with metronidazole 1000 mg daily had no definite effect on the drainage. He was referred to the University of British Columbia in 1987 because of a chronic deep perineal wound and scrotal fistula; the wound was debrided and the fistula excised. From July 1987 to December 1987, he had repeated surgical debridements with excision of the perineal skin. By July 1988, the perineal skin had completely healed. Case 5: A 28-year-old man initially noticed bleeding from his rectum in 1965. A sigmoidoscopic examination showed segmental inflammatory changes, and 'colitis' was diagnosed; he was treated with sulphasalazine. Symptoms resolved after 14 months, and medications were discontinued.
In 1985, bloody diarrhea recurred; results of fecal cultures and parasite studies were negative. Sulphasalazine was associated with symptom resolution, then recurrence. Colonoscopy showed segmental mucosal inflammatory changes with focal aphthoid and serpiginous ulcers; biopsies showed granulomatous inflammation consistent with Crohn's disease. In addition, a localized rectal cancer was detected. Low anterior resection showed that the tumour had infiltrated the serosa. Subsequent sulphasalazine treatment was associated with resolution of his diarrhea. Results of a colonoscopy in 1987 were normal, except for the presence of a few scattered aphthoid ulcers; results of biopsies from uninvolved colonic mucosa were normal. Results of laboratory tests, including liver chemistry tests and carcinoembryonic antigen, as well as abdominal-pelvic ultrasound studies, were normal. Case 6: A 64-year-old male physician developed rectal stump cancer in 1998. 'Colitis' was diagnosed in 1958, and a subtotal colectomy was done. An ileostomy was created with a rectal stump. He remained well until 1988, when he was hospitalized for a clinical diagnosis of a bowel obstruction. He was reluctant to have any further surgical treatment. Over the past five years, sigmoidoscopic examinations of a rectal stump revealed some inflammatory changes; there were no granulomas. He was treated with azathioprine, intermittent prednisone and corticosteroid enemas. In 1998, a fistulous tract developed from the apex of the rectal stump to the small bowel, and mucosal biopsies from the rectal stump showed focal dysplastic change. He was referred for a second opinion in 1998. Examination revealed an anorectal stricture, but a flexible sigmoidoscopy showed a diffusely hyperemic and friable rectal mucosa. Biopsies showed dysplastic colonic mucosal changes with invasive rectal carcinoma. An abdominoperineal resection was done, with removal of the rectal stump and fistulous tract. Pathological evaluation showed an infiltrating, moderately differentiated adenocarcinoma extending into the subserosal mesentery; changes of Crohn's disease with fissuring ulceration and subserosal abscess formation; and an unexpected focal squamous cell carcinoma at the anorectal junction. Lymph nodes in the resected specimen were negative for any metastatic neoplasm. Subsequently, radiation treatment and a course of chemotherapy were completed.
RESULTS

Patient population:
A total of 877 patients with Crohn's disease were evaluated over a period of 20 years. In this group, there were 385 men (43.9%) and 492 women (12) . The mean follow-up period for the total patient group was 7.8 years. For the six men with Crohn's disease described in the present report who developed colorectal cancer, Table 1 details the age and year of diagnosis of the Crohn's disease, site of disease, clinical behaviour (penetrating or stricturing), and the pharmacological and/or surgical treatment received. The mean age at diagnosis of the patients with Crohn's disease who developed colorectal cancer was higher than the mean age of this Crohn's disease population. All six had colonic involvement and, in four, only colonic disease was detected. The clinical behaviour of the Crohn's disease was classified as penetrating or perforating in four of six patients, and two patients developed a fistulous tract. Four patients required at least one surgical procedure for their Crohn's disease; of these, three had a rectal stump left in situ, each for over 10 years. Colorectal cancer: Table 2 lists details related to the diagnosis of colorectal cancer in the six men with Crohn's disease, including the age and year of diagnosis of colorectal cancer, the estimated number of years from the diagnosis of Crohn's disease to the diagnosis of colorectal cancer, the site and location of metastatic disease, histological types of colorectal cancer and treatment received. The ages at diagnosis of colorectal cancer for this group of six men ranged from 30 years to 59 years and, for most patients, the mean estimated duration from the time of diagnosis of Crohn's disease to the time of diagnosis of colorectal cancer was over 20 years. Of these cancers, all were located in the rectum and most, at the time of diagnosis, were advanced. To date, two patients have died. Three patients had rectal stump cancer; dysplastic mucosal changes were detected in one of these patients before the diagnosis of colorectal cancer. Although an adenocarcinoma was diagnosed in all six patients, a small squamous cell cancer was also detected at the anorectal junction in the resected surgical specimen of one patient.
Other malignant diseases:
Other malignancies recorded to date in the overall population of 877 patients with Crohn's disease have included two malignant melanomas (one man, one woman; both deceased), one glioblastoma (man; deceased), one atrial myxoma (man), one cervical cancer (woman), one appendiceal carcinoid (woman), one myeloma (man; deceased), two leukemia (two men; both deceased), one Hodgkin's disease (woman) and one small bowel carcinoma (woman).
DISCUSSION
Previous studies from tertiary care centres in the United
States and the United Kingdom have suggested that patients with Crohn's disease have an increased risk of colorectal cancer (9-11), as well as an excess mortality attributed to digestive tract tumours (13). Weedon et al (9) , at the Mayo Clinic, described colorectal cancer complicating the course of Crohn's disease in eight of 449 patients (or approximately 1.2%), for an estimated 20 times greater risk than that of a control population. Similarly, Gyde et al (10) reported an approximately fourfold increased risk in patients with Crohn's disease from the United Kingdom. Subsequently, in a survey of 126 individual gastroenterologists from the United States, not necessarily employed in the tertiary care setting, Korelitz (14) described 54 patients with colorectal cancer from an estimated population of 16,469 patients with Crohn's disease (approximately 0.33%), suggesting an increased risk of colorectal cancer in patients with Crohn's disease, but the magnitude of this risk was not clear. To date, specific data from Canada on col- orectal cancer complicating Crohn's disease are very limited. The present study evaluated a single clinician database of 877 patients from a teaching hospital setting; altogether, a total of six patients (approximately 0.68%) with colorectal cancer complicating Crohn's disease were detected. This number approximates the increased risk of colorectal cancer reported for patients with Crohn's disease, even though the number of patients reported in these larger centre studies is smaller (9) (10) (11) 14) . Further studies, therefore, are needed to estimate more precisely the overall experience in Canada with colorectal cancer complicating Crohn's disease because, in the present study, the findings may not be entirely representative and the follow-up period for all 877 patients (ie, mean 7.8 years) was limited.
The clinical features of patients with colorectal cancer in the present study were similar to those noted in earlier studies, including the long history of Crohn's disease, often over 20 years, predating the development of colorectal cancer; the relatively young age at the time of the colorectal cancer diagnosis compared with the more typical age of diagnosis in patients without Crohn's disease; and the apparent predilection for other histopathological types, such as mucinous adenocarcinoma (15) . This study also confirmed observations of previous studies that documented the presence of cancer in bypassed segments of the small intestine and colon (15) (16) (17) in patients with Crohn's disease. Finally, this series included a patient with squamous cell carcinoma in a rectal stump -a finding previously described only in a patients with a rectal stump following surgery for ulcerative colitis rather than Crohn's disease (18) .
Three of six patients with Crohn's disease involving the colon in the present series had rectal stump cancer. For each patient, surgical treatment, including creation of a rectal stump, had been done more than 10 years earlier.
Others have also observed this phenomenon in patients with both ulcerative colitis and Crohn's disease (15, 19, 20) . The precise cause for these findings is not clear. Interestingly, Sachar (21) previously argued, possibly correctly, that the prolonged presence of unresected disease per se, rather than bypassed or excluded mucosa, is the principal risk factor for the development of colorectal cancer. However, others (22) have conceptualized that 'misplaced' epithelium in either ulcerative colitis or Crohn's disease of the colon is most critical for later development of malignant mucosal changes. Prior experimental animal studies have provided ample evidence that other factors should be considered in the etiopathogenesis of colorectal cancer in bypassed intestine. In carcinogen-treated animals with bypassed intestine, increased numbers of intestinal, including colorectal, cancers develop, especially in the region of anastomotic suture lines (23, 24) . Although the problem of anastomotic recurrence after resection for colorectal cancer remains a very significant concern (25), the possible role of the anastomotic suture per se has also been explored as an independent risk factor for colorectal cancer in this experimental model (26) . These studies demonstrated that slowly absorbed or nonabsorbable suture materials, such as silk, promoted local colorectal tumour development in a carcinogen-induced animal model; moreover, multifilament stainless steel suture material also enhanced tumour development at a more distal or 'downstream' site (26) . Other investigators have suggested that these changes may be due, in part, to hyperplastic or proliferative changes near the colonic anastomosis in experimental carcinogenesis (27) or in more distal rectal mucosa after jejunoileal bypass for morbid obesity (28) . Further studies to elucidate factors that might promote the development of colorectal cancer in the bypassed rectal stump mucosa of patients with inflammatory bowel disease are needed. Nevertheless, part of the increased risk of colorectal cancer in the patients with Crohn's disease in the present study may have been related to the presence of a rectal stump, rather than to Crohn's disease per se.
In spite of the findings of the present study, it would be inappropriate to make any meaningful recommendations for surveillance programs in patients with Crohn's disease, especially because the mean duration of follow-up in this single clinician practice experience was limited and was not uniform. Moreover, in this series of patients, cancer was accompanied by, but not preceded by, confirmed dysplastic mucosal changes in only one patient. Therefore, strong recommendations for any specific program of periodic or systematic surveillance to detect dysplasia or early carcinoma cannot be provided on the basis of the present investigation. However, it still seems prudent to follow these patients with Crohn's disease closely, with periodic endoscopic biopsy evaluation, especially in those with a surgically created rectal stump. More refined studies to define the precise role of surveillance programs in this subset of patients with Crohn's disease are still needed.
